Spectrum of electrpphysiologic and electropharmacologic characteristics of verapamil-sensitive ventricular tachycardia in patients without structural heart disease

American Journal of Cardiology

Volumn 77, Issue 11, 1996, Pages 967-973

  Lee, Kathy L ^a   Lauer, Michael R ^a   Young, Charlie ^a   Lai, Wen Ter ^a   Tai, Yau Ting ^a   Chun, Hingson ^a   Liem, L Bing ^a   Sung, Ruey J ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ESMOLOL; ISOPRENALINE; PROPRANOLOL; VERAPAMIL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG SENSITIVITY; FEMALE; HEART ATRIUM PACING; HEART ELECTROPHYSIOLOGY; HEART LEFT BUNDLE BRANCH BLOCK; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE PACING; HEART VENTRICLE TACHYCARDIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; SUPRAVENTRICULAR PREMATURE BEAT;

ADENOSINE; ADULT; BUNDLE-BRANCH BLOCK; CATECHOLAMINES; ELECTROCARDIOGRAPHY; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; ISOPROTERENOL; MALE; MIDDLE AGED; TACHYCARDIA, VENTRICULAR; VERAPAMIL;

EID: 0029888483     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00011-2     Document Type: Article

References (32)

1. Beihassen B, Shapiro I, Pelleg A, Copperman I, Laniado S. Idiopathic recurrent sustained ventricular tachycardia responsive to verapamil: an ECG-electrophysiologic entity. Am Heart J 1984;108:1034-1037.
2. German LD, Packer DL, Bardy GH, Gallagher JJ. Ventricular tachycardia induced by atrial stimulation in patients without symptomatic cardiac disease. Am J Cardiol 1983;52:1202-1207.
3. Klein GJ, Millman PJ, Yee R. Recurrent ventricular tachycardia responsive to verapamil. PACE Pacing Clin Electrophysiol 1984;7:938-948.
4. Sung RJ, Shapiro WA, Shen EN, Morady F, David J. Effects of verapamil on ventricular tachycardias possibly caused by reentry, automaticity, and triggered activity. J Clin Invest 1983;72:350-360.
5. Ohe T, Shimomura K, Aihara N, Kamakura S, Matsuhisa M, Sata I, Nagagawa H, Shimizu A. Idiopathic sustained left ventricular tachycardia: clinical and electrophysiologic characteristics. Circulation 1988;77:560-568.
6. Lauer MR, Liem LB, Young C, Sung R. Cellular and clinical electrophysiology of verapamil-sensitive ventricular tachycardia. J Cardiovasc Electrophysiol 1992;3:500-514.
7. Sung RJ, Keung EC, Nguyen NX, Huycke EC. Effects of β-adrenergic blockade on verapamil-responsive and verapamil-irresponsive sustained ventricular tachycardias. J Clin Invest 1988;81:688-699.
8. Sung RJ, Blanski L, Kirshembaum J, MacCosbe P, Turlapaty P, Laddu AR, and the Esmolol Research Group. Clinical experience with esmolol, a short acting beta-adrenergic blocker in cardiac arrhythmias and myocardial ischaemia. Clin Pharmacol 1986;26(suppl A):A15-A26.
9. Jose AD, Taylor RR. Autonomie blockade by propranolol and atropine to study intrinsic myocardial function in man. J Clin Invest 1969;48:1769-1781.
10. Lerman BB, Belardinelli L, West GA, Berne R, DiMarco JP. Adenosine-sensitive ventricular tachycardia: evidence suggesting cyclic AMP-triggered activity. Circulation 1986;74:270-280.
11. Griffith MJ, Garratt CJ, Rowland E, Ward DE, Camm AJ. Effects of intravenous adenosine on verapamil-sensitive idiopathic ventricular tachycardia. Am J Cardiol 1994;73:759-764.
12. Cranefield PF. Action potentials, afterpotentials, and arrhythmias. Circ Res 1977;41:415-423.
13. Johnson NJ, Rosen MR. The distinction between triggered and other cardiac arrhythmias. In: Brugada P, Wellens HJJ, eds. Cardiac Arrhythmias: Where to Go from Here. Mount Kisco, New York: Futura Publishing Co Inc, 1987:129-145.
14. Zipes DP, Foster PR, Troup PJ, Pederson DH. Atrial induction of ventricular tachycardia: reentry versus triggered automaticity. Am J Cardiol 1979;44:1-8.
15. Wellens HJJ, Bar FW, Farre J, Ross DL, Wiener I, Vanagt EJ. Initiation and termination of ventricular tachycardia by supraventricular stimuli: incidence and electrophysiologic determinants as observed during programmed stimulation of the heart. Am J Cardiol 1980;46:576-582.
16. Tai YT, Fong PC, Lau CP, Chow WH, Cheng CH. Reentrant fascicular tachycardia with cycle length alternans: insight into the tachycardia mechanism and origin. PACE Pacing Clin Electrophysiol 1990;13:900-907.
17. Tai YT, D'Onofrio A, Bourke JP, Campbell RWF. Left posterior fascicular tachycardia due to localized microreentry. Eur Heart J 1990;11:949-953.
18. Brugada P, Wellens HJJ. Entrainment as an electrophysiologic phenomenon. J Am Coll Cardiol 1984;44:705-713.
19. Okumura K, Olshansky B, Henthorn RW, Epstein AE, Plumb V, Waldo AL. Demonstration of the presence of slow conduction during sustained ventricular tachycardia in man: use of transient entrainment of the tachycardia. Circulation 1987;95:359-378.
20. Okumura K, Matsuyama K, Miyagi H, Tsuchiya T, Yasue H. Entrainment of idiopathic ventricular tachycardia of left ventricular origin with evidence for reentry with an area of slow conduction and effect of verapamil. Am J Cardiol 1988;62:727-732.
21. Lerman BB, Belardinelli L. Cardiac electrophysiology of adenosine: basic and clinical concepts. Circulation 1991;83:1499-1509.
22. Schmitz W, Bohm M, Bruckner R, Burmann H, Meyer W, Neumann J, Nose M, Scholz H. Relationship between the effects of cAMP-increasing agents and adenosine in the mammalian heart. In: Stefanovich V, Rudolphi K, Schubert P, eds. Adenosine: Receptors and Modulation of Cell Function. Oxford: Oxford IRL Press, 1985:295-305.
23. Scholz H, Bohm M, Bruckner R, Neumann J, Schmitz W. Mechanism of the "antiadrenergic" effects of adenosine on myocardial force of contraction. In: Gerlach E, Becker BF, eds. Topics and Perspectives in Adenosine Research. Tokyo: Springer-Verlag, 1987:369-382.
24. 1-adenosine receptor-mediated inhibition of isoproterenol-stimulated protein phosphorylalion in ventricular myocytes: evidence against a cAMP-dependent effect. Circ Res 1993;72:65-74.
25. Romano FD, Fenton RA, Dobson JG. The adenosine receptor agonist, phenylisopropyladenosine, reduces high affinity isoproterenol binding to the beta-adrenergic receptor of rat myocardial membranes. Second Messengers Phosphoproteins 1988;12:29-43.
26. 1 adenosine receptors in atrial and ventricular myocardium from diseased human hearts. Circ Res 1989;65:1201-1211.
27. Wu SN, Linden J, Visentin S, Boykin M, Belardinelli L. Enhanced sensitivity of heart cells to adenosine and upregulation of receptor numbers after treatment of guinea pigs with theophylline. Circ Res 1989;65:1066-1077.
28. 1-adenosine receptors in embryonic chicken heart. Am J Physiol 1989;256:H321-H327.
29. Zipes DP, Niyazaki T. The autonomic nervous system and the heart: basis for understanding interactions and effects on arrhythmia development. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, Pennsylvania: WB Saunders Company, 1990;312-330.
30. Berne RM, Rubio R. Coronary circulation. In: Berne RM, Sperelakis N, Geiger SR, eds. Handbook of Physiology: Section 2, The Cardiovascular System. Bethesda, Maryland: American Physiological Society, 1979;897-902.
31. Iskandrian AS, Hakki AH, Laddu A. Effects of esmolol on cardiac function: evaluation by noninvasive techniques. Am J Cardiol 1985;56:27F-32F.
32. Lauer MR, Young C, Liem LB, Sung RJ. Efficacy of adenosine in terminating catecholamine-dependent supraventricular tachycardia. Am J Cardiol 1994;73:38-42.